Shandong Medireal Biopharmaceutical Technology Co., Ltd. was established on September 26, 2022. It currently operates with comprehensive offices, a financial center, a research and development center, and import-export business. Its production bases are located in Weifang Binhai Development Zone, Dongying Port Economic Development Zone, and Hekou Economic Development Zone in Dongying City, Shandong Province.

The company's main business includes: amino acids and their derivatives, biopharmaceutical products, high-end pharmaceutical products, and custom synthesis products. The company's projects are positioned with a high starting point, advanced technology, low-carbon environmental protection, and safety.

The company currently employs over 300 staff (including production personnel), with a total land area of more than 400 acres and fixed assets exceeding 200 million RMB (as of 2022). The company is in a phase of rapid development and expansion, with its annual output value doubling in growth.